[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Idarubicin.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Idarubicin.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Idarubicin.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Idarubicin.]
[L04AA27, fingolimod, Idarubicin may increase the immunosuppressive activities of Fingolimod.]
[J01EC02, sulfadiazine, The metabolism of Idarubicin can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Idarubicin can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Idarubicin.]
[J01EC03, sulfamoxole, The metabolism of Idarubicin can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Idarubicin can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Idarubicin can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Idarubicin can be decreased when combined with Sulfisoxazole.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Idarubicin.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Idarubicin.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Idarubicin.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Idarubicin.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Idarubicin.]
[G03BA03, testosterone, The metabolism of Idarubicin can be decreased when combined with Testosterone.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Idarubicin.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Tetracaine.]
[A04AD10, dronabinol, The metabolism of Idarubicin can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Idarubicin.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Idarubicin.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Eribulin.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Idarubicin is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Idarubicin.]
[N05AC02, thioridazine, The metabolism of Idarubicin can be decreased when combined with Thioridazine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Idarubicin.]
[B01AC05, ticlopidine, The metabolism of Idarubicin can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Idarubicin can be decreased when combined with Timolol.]
[A10BB05, tolazamide, The metabolism of Idarubicin can be decreased when combined with Tolazamide.]
[V04CA01, tolbutamide, The metabolism of Idarubicin can be decreased when combined with Tolbutamide.]
[N02AX02, tramadol, The metabolism of Idarubicin can be decreased when combined with Tramadol.]
[N06AF04, tranylcypromine, The metabolism of Idarubicin can be decreased when combined with Tranylcypromine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Idarubicin.]
[N06AX05, trazodone, The metabolism of Idarubicin can be decreased when combined with Trazodone.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Idarubicin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Idarubicin.]
[C03AA06, trichlormethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Idarubicin.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Idarubicin.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Idarubicin.]
[N03AC02, trimethadione, The metabolism of Idarubicin can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Idarubicin can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Idarubicin.]
[R06AC04, tripelennamine, The metabolism of Idarubicin can be decreased when combined with Tripelennamine.]
[N06AX24, vilazodone, The metabolism of Idarubicin can be decreased when combined with Vilazodone.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Idarubicin.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Belimumab.]
[L02BX03, abiraterone, The metabolism of Idarubicin can be decreased when combined with Abiraterone.]
[J05AG05, rilpivirine, The metabolism of Idarubicin can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Idarubicin.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Idarubicin is combined with Belatacept.]
[B01AF01, rivaroxaban, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Idarubicin.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Ticagrelor is combined with Idarubicin.]
[C08DA01, verapamil, The metabolism of Idarubicin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Idarubicin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Vinblastine is combined with Idarubicin.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Vincristine is combined with Idarubicin.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Idarubicin.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Idarubicin.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Warfarin is combined with Idarubicin.]
[S01AA13, fusidic acid, The metabolism of Idarubicin can be decreased when combined with Fusidic acid.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Idarubicin.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Idarubicin.]
[L01EC01, vemurafenib, The metabolism of Idarubicin can be decreased when combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Brentuximab vedotin.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Idarubicin.]
[R03DC01, zafirlukast, The metabolism of Idarubicin can be decreased when combined with Zafirlukast.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Idarubicin.]
[N02BA01, aspirin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Idarubicin.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ruxolitinib.]
[G04BD07, tolterodine, The metabolism of Idarubicin can be decreased when combined with Tolterodine.]
[C07AB03, atenolol, The metabolism of Idarubicin can be decreased when combined with Atenolol.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Idarubicin.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Idarubicin.]
[J02AC03, voriconazole, The metabolism of Idarubicin can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Idarubicin.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Idarubicin is combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Idarubicin.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Azacitidine is combined with Idarubicin.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Azathioprine is combined with Idarubicin.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Idarubicin.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Idarubicin.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Idarubicin.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Idarubicin.]
[L01FD02, pertuzumab, The risk or severity of cardiotoxicity can be increased when Idarubicin is combined with Pertuzumab.]
[A08AA11, lorcaserin, The metabolism of Idarubicin can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Idarubicin can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Idarubicin can be decreased when combined with Cobicistat.]
[L02BB04, enzalutamide, The serum concentration of Idarubicin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Bosutinib.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Idarubicin is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Idarubicin.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Idarubicin is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Aldosterone.]
[L01EX05, regorafenib, The metabolism of Idarubicin can be decreased when combined with Regorafenib.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may decrease the cardiotoxic activities of Idarubicin.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Bendamustine.]
[N06DA02, donepezil, The metabolism of Idarubicin can be decreased when combined with Donepezil.]
[L04AA29, tofacitinib, Idarubicin may increase the immunosuppressive activities of Tofacitinib.]
[G04BD10, darifenacin, The metabolism of Idarubicin can be decreased when combined with Darifenacin.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Idarubicin.]
[G04BE03, sildenafil, The metabolism of Idarubicin can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Idarubicin.]
[B01AF02, apixaban, The risk or severity of bleeding can be increased when Apixaban is combined with Idarubicin.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Idarubicin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Idarubicin can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Idarubicin.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Idarubicin is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Idarubicin can be decreased when combined with Ospemifene.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Idarubicin is combined with Dimethyl fumarate.]
[M04AB03, benzbromarone, The metabolism of Idarubicin can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Idarubicin can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Idarubicin can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Idarubicin is combined with Everolimus.]
[N04AC01, benztropine, The metabolism of Idarubicin can be decreased when combined with Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Idarubicin can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Idarubicin.]
[C08EA02, bepridil, The metabolism of Idarubicin can be decreased when combined with Bepridil.]
[L03AA14, lipegfilgrastim, Idarubicin may increase the myelosuppressive activities of Lipegfilgrastim.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Idarubicin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Idarubicin.]
[C07AB04, acebutolol, The metabolism of Idarubicin can be decreased when combined with Acebutolol.]
[L04AA32, apremilast, The metabolism of Idarubicin can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Idarubicin.]
[S01ED02, betaxolol, The metabolism of Idarubicin can be decreased when combined with Betaxolol.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Idarubicin.]
[L04AC11, siltuximab, The metabolism of Idarubicin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Idarubicin can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Idarubicin.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Vedolizumab.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Acenocoumarol is combined with Idarubicin.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Idarubicin is combined with Belinostat.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Idelalisib.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Idarubicin.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Idarubicin is combined with Peginterferon beta-1a.]
[A16AX10, eliglustat, The metabolism of Idarubicin can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Idarubicin can be decreased when combined with Oritavancin.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Decitabine.]
[N04AA02, biperiden, The metabolism of Idarubicin can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Pirfenidone.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Idarubicin.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Olaparib.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Dicoumarol is combined with Idarubicin.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Edoxaban is combined with Idarubicin.]
[N06AX11, mirtazapine, The metabolism of Idarubicin can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Idarubicin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Palbociclib.]
[L01XH03, panobinostat, The metabolism of Idarubicin can be decreased when combined with Panobinostat.]
[N02BE01, acetaminophen, The metabolism of Idarubicin can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Idarubicin.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Tioclomarol is combined with Idarubicin.]
[J05AP06, asunaprevir, The metabolism of Idarubicin can be decreased when combined with Asunaprevir.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Idarubicin.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Idarubicin.]
[A04AD14, rolapitant, The metabolism of Idarubicin can be decreased when combined with Rolapitant.]
[A02BC03, lansoprazole, The metabolism of Idarubicin can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Idarubicin.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Idarubicin can be decreased when combined with Isavuconazole.]
[A10BB31, acetohexamide, The metabolism of Idarubicin can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Idarubicin.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Idarubicin.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ixekizumab.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Bupivacaine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Idarubicin.]
[N07BC01, buprenorphine, The metabolism of Idarubicin can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, The metabolism of Idarubicin can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Busulfan is combined with Idarubicin.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Idarubicin.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Idarubicin.]
[S01GX07, azelastine, The metabolism of Idarubicin can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Idarubicin can be decreased when combined with Rucaparib.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Brodalumab.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Idarubicin.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Idarubicin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Oxybuprocaine.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Idarubicin.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Idarubicin.]
[J05AE09, tipranavir, The metabolism of Idarubicin can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Idarubicin.]
[L04AB02, infliximab, The metabolism of Idarubicin can be increased when combined with Infliximab.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Idarubicin can be increased when combined with Delafloxacin.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Idarubicin.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Idarubicin.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Idarubicin.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Idarubicin is combined with Vorinostat.]
[J05AG03, efavirenz, The metabolism of Idarubicin can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Idarubicin.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Idarubicin.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Idarubicin.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Idarubicin.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Idarubicin is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Idarubicin.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Idarubicin.]
[C01AA02, acetyldigoxins, Acetyldigoxin may decrease the cardiotoxic activities of Idarubicin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Capsaicin.]
[L02BB05, apalutamide, The metabolism of Idarubicin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Idarubicin.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Idarubicin.]
[C07AG02, carvedilol, The metabolism of Idarubicin can be decreased when combined with Carvedilol.]
[N03AX24, cannabidiol, The metabolism of Idarubicin can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Idarubicin can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Baricitinib.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Idarubicin.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Idarubicin.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Idarubicin.]
[L01XX62, ivosidenib, The metabolism of Idarubicin can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Idarubicin.]
[N03AX17, stiripentol, The metabolism of Idarubicin can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Idarubicin.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Idarubicin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Idarubicin.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Idarubicin.]
[L04AA39, emapalumab, The metabolism of Idarubicin can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Idarubicin.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ravulizumab.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Idarubicin.]
[B01AC23, cilostazol, The risk or severity of bleeding can be increased when Cilostazol is combined with Idarubicin.]
[P02BX04, triclabendazole, The metabolism of Idarubicin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Idarubicin.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Idarubicin is combined with Siponimod.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Idarubicin.]
[N05BA09, clobazam, The metabolism of Idarubicin can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Idarubicin is combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Idarubicin can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Idarubicin can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Idarubicin is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Risankizumab.]
[L01EM03, alpelisib, The serum concentration of Idarubicin can be decreased when it is combined with Alpelisib.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Upadacitinib.]
[L01EJ02, fedratinib, The metabolism of Idarubicin can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The metabolism of Idarubicin can be decreased when combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Idarubicin.]
[C03AA09, cyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Idarubicin.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Idarubicin.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Idarubicin is combined with Deflazacort.]
[L01FD01, trastuzumab, The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Idarubicin.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Trastuzumab emtansine.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Idarubicin is combined with Diroximel fumarate.]
[G03AC09, desogestrel, The metabolism of Idarubicin can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Idarubicin.]
[A16AX16, givosiran, The serum concentration of Idarubicin can be increased when it is combined with Givosiran.]
[R06AB02, dexchlorpheniramine, The metabolism of Idarubicin can be decreased when combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Idarubicin can be decreased when combined with Avapritinib.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Teprotumumab.]
[M01AX21, diacetylrhein, The metabolism of Idarubicin can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Idarubicin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Idarubicin can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Idarubicin.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Idarubicin.]
[N02CC06, eletriptan, The metabolism of Idarubicin can be decreased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Idarubicin can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Idarubicin.]
[C08CA16, clevidipine, The metabolism of Idarubicin can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Idarubicin can be decreased when combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Idarubicin.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Idarubicin.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Idarubicin can be decreased when combined with Trospium.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Idarubicin.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Idarubicin is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Stepronin.]
[P01BB01, proguanil, The metabolism of Idarubicin can be decreased when combined with Proguanil.]
[L04AC19, satralizumab, The serum concentration of Idarubicin can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The metabolism of Oliceridine can be decreased when combined with Idarubicin.]
[P01BA01, chloroquine, The metabolism of Idarubicin can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Idarubicin can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Idarubicin.]
[R06AB04, chlorpheniramine, The metabolism of Idarubicin can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Idarubicin can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The metabolism of Idarubicin can be decreased when combined with Chlorpropamide.]
[M03BB03, chlorzoxazone, The metabolism of Idarubicin can be decreased when combined with Chlorzoxazone.]
[A11CC05, cholecalciferol, The metabolism of Idarubicin can be decreased when combined with Cholecalciferol.]
[M01AB08, etodolac, The metabolism of Idarubicin can be decreased when combined with Etodolac.]
[B06AC06, berotralstat, The metabolism of Idarubicin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Lonafarnib can be decreased when combined with Idarubicin.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fludarabine is combined with Idarubicin.]
[L01FD06, margetuximab, The risk or severity of cardiotoxicity can be increased when Margetuximab is combined with Idarubicin.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Voclosporin.]
[L01EX21, tepotinib, The metabolism of Idarubicin can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Idarubicin can be decreased when combined with Felbamate.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Idarubicin.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Idarubicin.]
[R03CC15, formoterol, The metabolism of Idarubicin can be decreased when combined with Formoterol.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ponesimod.]
[S01LA08, bevacizumab, The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Idarubicin.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Idarubicin.]
[A02BA01, cimetidine, The metabolism of Idarubicin can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Idarubicin can be decreased when combined with Cinnarizine.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Idarubicin.]
[N06AB04, citalopram, The metabolism of Idarubicin can be decreased when combined with Citalopram.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Idarubicin is combined with Pegcetacoplan.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Idarubicin is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Idarubicin.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Anifrolumab.]
[R06AA04, clemastine, The metabolism of Idarubicin can be decreased when combined with Clemastine.]
[A10BB12, glimepiride, The metabolism of Idarubicin can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Idarubicin.]
[N06AX25, St. John's wort extract, The metabolism of Idarubicin can be decreased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Idarubicin can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Idarubicin.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Idarubicin.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Levobupivacaine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Idarubicin.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Idarubicin.]
[C01EB24, mavacamten, The serum concentration of Idarubicin can be decreased when it is combined with Mavacamten.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Deucravacitinib.]
[A04AA01, ondansetron, The metabolism of Idarubicin can be decreased when combined with Ondansetron.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Idarubicin is combined with Clozapine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Idarubicin can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The metabolism of Idarubicin can be decreased when combined with Codeine.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Idarubicin is combined with Leflunomide.]
[A10BX03, nateglinide, The metabolism of Idarubicin can be decreased when combined with Nateglinide.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Nelarabine.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Idarubicin.]
[M01AH03, valdecoxib, The metabolism of Idarubicin can be decreased when combined with Valdecoxib.]
[C01AA06, lanatoside C, Lanatoside C may decrease the cardiotoxic activities of Idarubicin.]
[N02CC05, almotriptan, The metabolism of Idarubicin can be decreased when combined with Almotriptan.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Idarubicin.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Idarubicin.]
[L01EA01, imatinib, The serum concentration of Idarubicin can be increased when it is combined with Imatinib.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Idarubicin.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Idarubicin.]
[C08CA11, manidipine, The metabolism of Idarubicin can be decreased when combined with Manidipine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Idarubicin.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Idarubicin can be decreased when combined with Mequitazine.]
[R06AE03, cyclizine, The metabolism of Idarubicin can be decreased when combined with Cyclizine.]
[N05AD03, metylperon, The metabolism of Idarubicin can be decreased when combined with Melperone.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Idarubicin.]
[C03AA07, cyclopenthiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Idarubicin.]
[L01AA01, cyclophosphamide, The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Idarubicin.]
[N06AX07, minaprine, The metabolism of Idarubicin can be decreased when combined with Minaprine.]
[S01XA18, cyclosporine, Idarubicin may increase the immunosuppressive activities of Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Idarubicin can be decreased when combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Idarubicin can be decreased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Idarubicin can be decreased when combined with Rosuvastatin.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Cytarabine is combined with Idarubicin.]
[M01AH05, etoricoxib, The metabolism of Idarubicin can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Idarubicin.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dactinomycin is combined with Idarubicin.]
[J04BA02, dapsone, The metabolism of Idarubicin can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Idarubicin.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Idarubicin.]
[A04AD11, nabilone, The metabolism of Idarubicin can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The metabolism of Idarubicin can be decreased when combined with Nabumetone.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Idarubicin.]
[N06AX06, nefazodone, The metabolism of Idarubicin can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Idarubicin can be decreased when combined with Nilutamide.]
[B01AX05, fondaparinux, The risk or severity of bleeding can be increased when Fondaparinux is combined with Idarubicin.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Idarubicin.]
[N06AB10, escitalopram, The serum concentration of Idarubicin can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Idarubicin.]
[N06AA01, desipramine, The metabolism of Idarubicin can be decreased when combined with Desipramine.]
[C01AA07, deslanoside, Deslanoside may decrease the cardiotoxic activities of Idarubicin.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Idarubicin.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Idarubicin.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Idarubicin can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Idarubicin can be decreased when combined with Dexfenfluramine.]
[L04AB04, adalimumab, The metabolism of Idarubicin can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Idarubicin can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The metabolism of Idarubicin can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Idarubicin can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, The metabolism of Idarubicin can be decreased when combined with Paramethadione.]
[N06AB05, paroxetine, The metabolism of Idarubicin can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Idarubicin can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Idarubicin can be decreased when combined with Diazepam.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Idarubicin can be decreased when combined with Diclofenac.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Idarubicin.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Pirarubicin.]
[L02AA01, diethylstilbestrol, The metabolism of Idarubicin can be decreased when combined with Diethylstilbestrol.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Difluocortolone.]
[C01AA04, digitoxin, Digitoxin may decrease the cardiotoxic activities of Idarubicin.]
[C01AA05, digoxin, Digoxin may decrease the cardiotoxic activities of Idarubicin.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Idarubicin.]
[N02AA03, hydromorphone, The metabolism of Idarubicin can be decreased when combined with Hydromorphone.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Idarubicin.]
[J05AE08, atazanavir, The metabolism of Idarubicin can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Idarubicin can be decreased when combined with Treprostinil.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Idarubicin can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Idarubicin can be decreased when combined with Dimethyl sulfoxide.]
[C05CA03, diosmin, The metabolism of Idarubicin can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Idarubicin.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Idarubicin.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Idarubicin.]
[A03FA02, cisapride, The metabolism of Idarubicin can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Sirolimus is combined with Idarubicin.]
[N05AL04, remoxipride, The metabolism of Idarubicin can be decreased when combined with Remoxipride.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Natalizumab.]
[S02AA12, rifamycin SV, The metabolism of Idarubicin can be decreased when combined with Rifamycin.]
[N05AX08, risperidone, The metabolism of Idarubicin can be decreased when combined with Risperidone.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Idarubicin.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Ropivacaine.]
[L01EX01, sunitinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Sunitinib.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Idarubicin.]
[S01BC05, ketorolac, The metabolism of Idarubicin can be decreased when combined with Ketorolac.]
[C01EB18, ranolazine, The serum concentration of Idarubicin can be increased when it is combined with Ranolazine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Idarubicin.]
[N06AA16, dothiepin, The metabolism of Idarubicin can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Idarubicin can be decreased when combined with Doxepin.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Doxorubicin is combined with Idarubicin.]
[N06AB06, sertraline, The metabolism of Idarubicin can be decreased when combined with Sertraline.]
[C10AA01, simvastatin, The metabolism of Idarubicin can be decreased when combined with Simvastatin.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Idarubicin.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Corticotropin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Temozolomide is combined with Idarubicin.]
[M01AC02, tenoxicam, The metabolism of Idarubicin can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Idarubicin can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Idarubicin.]
[N06BA09, atomoxetine, The metabolism of Idarubicin can be decreased when combined with Atomoxetine.]
[C03CA04, torsemide, The metabolism of Idarubicin can be decreased when combined with Torasemide.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Idarubicin.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Trilostane is combined with Idarubicin.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Idarubicin is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Idarubicin.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Idarubicin.]
[S01GX10, epinastine, The metabolism of Idarubicin can be decreased when combined with Epinastine.]
[N06AX16, venlafaxine, The metabolism of Idarubicin can be decreased when combined with Venlafaxine.]
[S01EA01, epinephrine, The metabolism of Idarubicin can be decreased when combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Idarubicin.]
[N05CF02, zolpidem, The metabolism of Idarubicin can be decreased when combined with Zolpidem.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Idarubicin.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Idarubicin.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carboplatin is combined with Idarubicin.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Idarubicin.]
[N03AG01, valproic acid, The metabolism of Idarubicin can be decreased when combined with Valproic acid.]
[H05BX01, cinacalcet, The metabolism of Idarubicin can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, The metabolism of Idarubicin can be decreased when combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Estramustine.]
[J04AK02, ethambutol, The metabolism of Idarubicin can be decreased when combined with Ethambutol.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Idarubicin can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Idarubicin can be decreased when combined with Ethinylestradiol.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Idarubicin.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Etidocaine.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Etoposide is combined with Idarubicin.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Idarubicin.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Idarubicin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Idarubicin.]
[R06AX12, terfenadine, The metabolism of Idarubicin can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Idarubicin can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Idarubicin can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Idarubicin.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Idarubicin.]
[B05AA05, dextran, The risk or severity of bleeding can be increased when Dextran is combined with Idarubicin.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Idarubicin.]
[C08CA02, felodipine, The metabolism of Idarubicin can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The metabolism of Idarubicin can be decreased when combined with Fenfluramine.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Idarubicin.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Idarubicin.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Idarubicin.]
[N07AX03, cevimeline, The metabolism of Idarubicin can be decreased when combined with Cevimeline.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Idarubicin.]
[J02AC01, fluconazole, The metabolism of Idarubicin can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Flucytosine is combined with Idarubicin.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Idarubicin.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Idarubicin.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Idarubicin.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Idarubicin.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Idarubicin can be decreased when combined with Ethanol.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Idarubicin.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Idarubicin.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Idarubicin.]
[N06AB03, fluoxetine, The serum concentration of Idarubicin can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Idarubicin.]
[N05AB02, fluphenazine, The metabolism of Idarubicin can be decreased when combined with Fluphenazine.]
[S01BC04, flurbiprofen, The metabolism of Idarubicin can be decreased when combined with Flurbiprofen.]
[J05AE10, darunavir, The metabolism of Idarubicin can be decreased when combined with Darunavir.]
[N06DA04, galantamine, The metabolism of Idarubicin can be decreased when combined with Galantamine.]
[C10AB04, gemfibrozil, The metabolism of Idarubicin can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Dasatinib.]
[J05AG04, etravirine, The metabolism of Idarubicin can be decreased when combined with Etravirine.]
[A10BB01, glyburide, The metabolism of Idarubicin can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Idarubicin can be decreased when combined with Gliclazide.]
[A10BB07, glipizide, The metabolism of Idarubicin can be decreased when combined with Glipizide.]
[N05CM18, dexmedetomidine, The metabolism of Idarubicin can be decreased when combined with Dexmedetomidine.]
[C02CA04, doxazosin, The metabolism of Idarubicin can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The risk or severity of adverse effects can be increased when Sorafenib is combined with Idarubicin.]
[C07AB09, esmolol, The metabolism of Idarubicin can be decreased when combined with Esmolol.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fluindione is combined with Idarubicin.]
[P01BX01, halofantrine, The metabolism of Idarubicin can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Idarubicin can be increased when it is combined with Haloperidol.]
[N01AB01, halothane, The metabolism of Idarubicin can be decreased when combined with Halothane.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Idarubicin.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Irinotecan is combined with Idarubicin.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Idarubicin.]
[C09CA01, losartan, The metabolism of Idarubicin can be decreased when combined with Losartan.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Idarubicin.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Idarubicin.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Idarubicin.]
[J05AG01, nevirapine, The metabolism of Idarubicin can be decreased when combined with Nevirapine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Nimesulide is combined with Idarubicin.]
[C03AA03, hydrochlorothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Idarubicin.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Idarubicin is combined with Hydrocortisone butyrate.]
[C03AA02, hydroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Idarubicin.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Hydroxychloroquine.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Idarubicin.]
[N05BB01, hydroxyzine, The metabolism of Idarubicin can be decreased when combined with Hydroxyzine.]
[R02AX02, ibuprofen, The metabolism of Idarubicin can be decreased when combined with Ibuprofen.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Idarubicin.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Antilymphocyte immunoglobulin (horse).]
[M01AG01, mefenamic acid, The metabolism of Idarubicin can be decreased when combined with Mefenamic acid.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Idarubicin is combined with Fluticasone furoate.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ifosfamide.]
[N06AA02, imipramine, The metabolism of Idarubicin can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Idarubicin is combined with Paclitaxel.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Idarubicin is combined with Tixocortol.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Topotecan is combined with Idarubicin.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Idarubicin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Idarubicin.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Idarubicin.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Articaine.]
[N05CH02, ramelteon, The metabolism of Idarubicin can be decreased when combined with Ramelteon.]
[C10AA06, cerivastatin, The metabolism of Idarubicin can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Idarubicin.]
[C07AA01, alprenolol, The metabolism of Idarubicin can be decreased when combined with Alprenolol.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Idarubicin.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Idarubicin.]
[N06AF05, iproniazid, The metabolism of Idarubicin can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Idarubicin can be decreased when combined with Atovaquone.]
[N04BX02, entacapone, The metabolism of Idarubicin can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Idarubicin can be decreased when combined with Isoniazid.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Idarubicin.]
[N06AX18, reboxetine, The metabolism of Idarubicin can be decreased when combined with Reboxetine.]
[L04AC07, tocilizumab, The metabolism of Idarubicin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Idarubicin.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Idarubicin.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Prasugrel is combined with Idarubicin.]
[J02AB02, ketoconazole, The metabolism of Idarubicin can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Idarubicin can be decreased when combined with Olanzapine.]
[L04AA24, abatacept, The metabolism of Idarubicin can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Idarubicin can be decreased when combined with Rotigotine.]
[C07AG01, labetalol, The metabolism of Idarubicin can be decreased when combined with Labetalol.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Idarubicin.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Idarubicin.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Idarubicin can be decreased when combined with Armodafinil.]
[N02CA07, lisuride, The metabolism of Idarubicin can be decreased when combined with Lisuride.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Idarubicin is combined with Lomustine.]
[C10AA02, lovastatin, The metabolism of Idarubicin can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Idarubicin.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Idarubicin is combined with Temsirolimus.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Idarubicin is combined with Pralatrexate.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Nilotinib.]
[N06AA21, maprotiline, The metabolism of Idarubicin can be decreased when combined with Maprotiline.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Idarubicin.]
[R06AE05, meclizine, The metabolism of Idarubicin can be decreased when combined with Meclizine.]
[C01AA08, medigoxin, Metildigoxin may decrease the cardiotoxic activities of Idarubicin.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Idarubicin.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Idarubicin.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Idarubicin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Melphalan is combined with Idarubicin.]
[N03AB04, mephenytoin, The metabolism of Idarubicin can be decreased when combined with Mephenytoin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Mepivacaine.]
[N05AC03, mesoridazine, The metabolism of Idarubicin can be decreased when combined with Mesoridazine.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Idarubicin.]
[A04AA04, dolasetron, The metabolism of Idarubicin can be decreased when combined with Dolasetron.]
[N07BC02, methadone, The metabolism of Idarubicin can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Idarubicin.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Methimazole is combined with Idarubicin.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Idarubicin.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Methotrexate is combined with Idarubicin.]
[N05AA02, methotrimeprazine, The metabolism of Idarubicin can be decreased when combined with Methotrimeprazine.]
[N02BG09, methoxyflurane, The metabolism of Idarubicin can be decreased when combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Idarubicin.]
[V04CG05, methylene blue, The metabolism of Idarubicin can be decreased when combined with Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Idarubicin.]
[A03FA01, metoclopramide, The metabolism of Idarubicin can be decreased when combined with Metoclopramide.]
[C07AB02, metoprolol, The metabolism of Idarubicin can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Idarubicin can be decreased when combined with Metronidazole.]
[C01BB02, mexiletine, The metabolism of Idarubicin can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Idarubicin.]
[S02AA13, miconazole, The metabolism of Idarubicin can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Idarubicin.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Idarubicin.]
[G03XB01, mifepristone, The metabolism of Idarubicin can be decreased when combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Idarubicin.]
[C09CA03, valsartan, The metabolism of Idarubicin can be decreased when combined with Valsartan.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The metabolism of Idarubicin can be decreased when combined with Lisdexamfetamine.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Idarubicin.]
[C01BD01, amiodarone, The metabolism of Idarubicin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Idarubicin.]
[A04AA05, palonosetron, The metabolism of Idarubicin can be decreased when combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Idarubicin can be increased when combined with Certolizumab pegol.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Ofatumumab.]
[L01EX03, pazopanib, The risk or severity of adverse effects can be increased when Idarubicin is combined with Pazopanib.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Idarubicin.]
[P01BA06, amodiaquine, The metabolism of Idarubicin can be decreased when combined with Amodiaquine.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Idarubicin.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Idarubicin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Idarubicin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Idarubicin.]
[L04AC03, anakinra, The metabolism of Idarubicin can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Idarubicin can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The metabolism of Idarubicin can be decreased when combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Idarubicin can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Idarubicin can be decreased when combined with Duloxetine.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Idarubicin.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Idarubicin is combined with Docetaxel.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Idarubicin.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Idarubicin.]
[N06AX23, desvenlafaxine, The metabolism of Idarubicin can be decreased when combined with Desvenlafaxine.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Idarubicin.]
[C10AD02, niacin, The metabolism of Idarubicin can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Idarubicin can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Idarubicin can be decreased when combined with Nicergoline.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Idarubicin.]
[C08CA05, nifedipine, The metabolism of Idarubicin can be decreased when combined with Nifedipine.]
[C02KX01, bosentan, The metabolism of Idarubicin can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Idarubicin.]
[R05DA07, noscapine, The metabolism of Idarubicin can be decreased when combined with Noscapine.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Idarubicin.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Idarubicin.]
[L04AC04, rilonacept, The metabolism of Idarubicin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Idarubicin can be decreased when combined with Omeprazole.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Idarubicin.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Idarubicin.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Idarubicin.]
[G04CA02, tamsulosin, The metabolism of Idarubicin can be decreased when combined with Tamsulosin.]
[C01AC01, ouabain, Ouabain may decrease the cardiotoxic activities of Idarubicin.]
[P02BA02, oxamniquine, The metabolism of Idarubicin can be decreased when combined with Oxamniquine.]
[A14AA08, oxandrolone, The metabolism of Idarubicin can be decreased when combined with Oxandrolone.]
[C07AA02, oxprenolol, The metabolism of Idarubicin can be decreased when combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Idarubicin can be decreased when combined with Oxycodone.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Idarubicin.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Idarubicin.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Idarubicin is combined with Paramethasone.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Idarubicin.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Idarubicin.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Penicillamine is combined with Idarubicin.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Idarubicin.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Idarubicin.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Idarubicin.]
[C04AD03, pentoxifylline, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Idarubicin.]
[C08EX02, perhexiline, The metabolism of Idarubicin can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Idarubicin can be decreased when combined with Perphenazine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Idarubicin.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Idarubicin.]
[A10BA01, phenformin, The metabolism of Idarubicin can be decreased when combined with Phenformin.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Phenindione is combined with Idarubicin.]
[N03AA02, phenobarbital, The metabolism of Idarubicin can be decreased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Phenprocoumon is combined with Idarubicin.]
[M02AA01, phenylbutazone, The metabolism of Idarubicin can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Idarubicin can be decreased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Idarubicin can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The metabolism of Idarubicin can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Idarubicin.]
[C07AA03, pindolol, The metabolism of Idarubicin can be decreased when combined with Pindolol.]
[J05AE01, saquinavir, The metabolism of Idarubicin can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Idarubicin can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The metabolism of Idarubicin can be decreased when combined with Pipotiazine.]
[S01BC06, piroxicam, The metabolism of Idarubicin can be decreased when combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Idarubicin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Idarubicin can be decreased when combined with Irbesartan.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Idarubicin.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Idarubicin.]
[A10BG02, rosiglitazone, The metabolism of Idarubicin can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The risk or severity of cardiotoxicity can be increased when Idarubicin is combined with Anastrozole.]
[A03AE01, alosetron, The metabolism of Idarubicin can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Idarubicin can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Idarubicin.]
[J05AE03, ritonavir, The metabolism of Idarubicin can be decreased when combined with Ritonavir.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Idarubicin.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Idarubicin.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Prednisolone is combined with Idarubicin.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Idarubicin.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Idarubicin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Idarubicin can be decreased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Idarubicin can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Idarubicin.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Idarubicin.]
[C10AB05, fenofibrate, The metabolism of Idarubicin can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The metabolism of Idarubicin can be decreased when combined with Prochlorperazine.]
[G03DA04, progesterone, The metabolism of Idarubicin can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Idarubicin can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Idarubicin can be decreased when combined with Promethazine.]
[C01BC03, propafenone, The metabolism of Idarubicin can be decreased when combined with Propafenone.]
[N01AX10, propofol, The metabolism of Idarubicin can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Idarubicin can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Idarubicin can be decreased when combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Idarubicin.]
[C01AB01, proscillaridin, Proscillaridin may decrease the cardiotoxic activities of Idarubicin.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Idarubicin.]
[R03DC03, montelukast, The metabolism of Idarubicin can be decreased when combined with Montelukast.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Idarubicin.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Idarubicin.]
[R06AC01, pyrilamine, The metabolism of Idarubicin can be decreased when combined with Mepyramine.]
[C01BA01, quinidine, The metabolism of Idarubicin can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Idarubicin can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Idarubicin can be decreased when combined with Ranitidine.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Idarubicin.]
[S01BC08, salicylic acid, The metabolism of Idarubicin can be decreased when combined with Salicylic acid.]
[N04BD01, selegiline, The metabolism of Idarubicin can be decreased when combined with Selegiline.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Idarubicin is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Idarubicin.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Idarubicin.]
[L01CD04, cabazitaxel, The risk or severity of adverse effects can be increased when Idarubicin is combined with Cabazitaxel.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Idarubicin.]
[L01CD03, paclitaxel poliglumex, The risk or severity of cardiotoxicity can be increased when Idarubicin is combined with Paclitaxel poliglumex.]
